- Home
- AVNT vs SWTX Comparison
AVNT vs SWTX Comparison
Compare AVNT & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNT
- SWTX
- Stock Information
- Founded
- AVNT 1927
- SWTX 2017
- Country
- AVNT United States
- SWTX United States
- Employees
- AVNT N/A
- SWTX N/A
- Industry
- AVNT Major Chemicals
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- AVNT Industrials
- SWTX Health Care
- Exchange
- AVNT Nasdaq
- SWTX Nasdaq
- Market Cap
- AVNT 3.4B
- SWTX 3.0B
- IPO Year
- AVNT 1993
- SWTX 2019
- Fundamental
- Price
- AVNT $37.88
- SWTX $46.52
- Analyst Decision
- AVNT Strong Buy
- SWTX Strong Buy
- Analyst Count
- AVNT 5
- SWTX 5
- Target Price
- AVNT $54.40
- SWTX $72.40
- AVG Volume (30 Days)
- AVNT 646.9K
- SWTX 1.9M
- Earning Date
- AVNT 05-06-2025
- SWTX 05-01-2025
- Dividend Yield
- AVNT 2.86%
- SWTX N/A
- EPS Growth
- AVNT 121.98
- SWTX N/A
- EPS
- AVNT 1.84
- SWTX N/A
- Revenue
- AVNT $3,240,400,000.00
- SWTX $191,589,000.00
- Revenue This Year
- AVNT $3.54
- SWTX $85.98
- Revenue Next Year
- AVNT $4.50
- SWTX $69.16
- P/E Ratio
- AVNT $20.04
- SWTX N/A
- Revenue Growth
- AVNT 3.11
- SWTX 3417.33
- 52 Week Low
- AVNT $36.01
- SWTX $28.21
- 52 Week High
- AVNT $54.68
- SWTX $62.00
- Technical
- Relative Strength Index (RSI)
- AVNT 39.32
- SWTX 46.08
- Support Level
- AVNT $36.01
- SWTX $40.98
- Resistance Level
- AVNT $40.01
- SWTX $51.43
- Average True Range (ATR)
- AVNT 1.07
- SWTX 2.26
- MACD
- AVNT -0.19
- SWTX -0.74
- Stochastic Oscillator
- AVNT 37.33
- SWTX 52.61
About AVNT Avient Corporation
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.